Traitement des carcinoses péritonéales d'origine colo-rectale. Quoi ...

Table 6. Prognostic Impact of Clinical Factors on Overall Survival by Univariate Analysis
Therapeutic Factor No.
Analyzed
months to 42 months, but that effect was not replicated
when the analysis was adjusted based on the center.
However, it is reasonable to assume that experience may
provide better patient selection, surgical expertise, and
postoperative management. A learning curve already
had been reported by several authors. Moran reported a
decreased mortality rate from 18% down to 3%, 21 The
Netherlands Cancer Institute reported a decrease in
mortality from 8% to 4%, 22 and Yan et al reported a
decrease from 7% to 1%. 23 All interventional complex
procedures have an inherent risk, and experience
undoubtedly diminishes but can never abolish this
risk. 24
Median
survival,
mo
Treatment of Peritoneal Carcinomatosis/Glehen et al
3-Year
Survival,
%
Preoperative systemic chemotherapy
Yes 633 31 43 30
No 580 45 55 43
5-Year
Survival,
%
Synchronous resection of liver metastasis .003
Yes 117 21 34 25
No 955 36 51 39
CCR category